Ambry Genetics’ Post

Did you know Ambry's Patient for Life program isn't just for exome testing? Neurological panels like NeurodevelopmentNext™ and EpilepsyNext-Expanded™ also qualify for proactive analysis to account for new gene disease associations, providing updated diagnoses to patients who receive expanded neurogenetics panels at Ambry. Genetic Counselor Victoria Suslovitch shares how one patient with a ZBTB20 mutation received answers. #PatientforLife #neurogenetics #AmbryKnowsGenes

Proactive, automatic reanalysis = up to date results = peace of mind for families and clinicians alike

Did you know there are over 6,000 different rare diseases affecting millions worldwide? There is a considerable overlap in clinical trials in cell and gene therapy. With rare disease, pediatric patients are truly complex and challenging. These trials represent a beacon of hope for children facing rare diseases. https://lnkd.in/ggfbqE_E #RareDiseaseMonth #RareDiseases #ClinicalTrials #ClinicalResearch #ShareYourColors #ShowYourRare

Did you know there are over 6,000 different rare diseases affecting millions worldwide? There is a considerable overlap in clinical trials in cell and gene therapy. With rare disease, pediatric patients are truly complex and challenging. These trials represent a beacon of hope for children facing rare diseases. https://lnkd.in/d-3jY2Wn #RareDiseaseMonth #RareDiseases #ClinicalTrials #ClinicalResearch #ShareYourColors #ShowYourRare

Did you know there are over 6,000 different rare diseases affecting millions worldwide? There is a considerable overlap in clinical trials in cell and gene therapy. With rare disease, pediatric patients are truly complex and challenging. These trials represent a beacon of hope for children facing rare diseases. https://lnkd.in/giQqwF9w #RareDiseaseMonth #RareDiseases #ClinicalTrials #ClinicalResearch #ShareYourColors #ShowYourRare

Did you know there are over 6,000 different rare diseases affecting millions worldwide? There is a considerable overlap in clinical trials in cell and gene therapy. With rare disease, pediatric patients are truly complex and challenging. These trials represent a beacon of hope for children facing rare diseases. https://lnkd.in/gk69z2zB #RareDiseaseMonth #RareDiseases #ClinicalTrials #ClinicalResearch #ShareYourColors #ShowYourRare

Did you know there are over 6,000 different rare diseases affecting millions worldwide? There is a considerable overlap in clinical trials in cell and gene therapy. With rare disease, pediatric patients are truly complex and challenging. These trials represent a beacon of hope for children facing rare diseases. https://lnkd.in/gUitb3Zr #RareDiseaseMonth #RareDiseases #ClinicalTrials #ClinicalResearch #ShareYourColors #ShowYourRare

Did you know there are over 6,000 different rare diseases affecting millions worldwide? There is a considerable overlap in clinical trials in cell and gene therapy. With rare disease, pediatric patients are truly complex and challenging. These trials represent a beacon of hope for children facing rare diseases. https://lnkd.in/gET4rmaF #RareDiseaseMonth #RareDiseases #ClinicalTrials #ClinicalResearch #ShareYourColors #ShowYourRare

Did you know there are over 6,000 different rare diseases affecting millions worldwide? There is a considerable overlap in clinical trials in cell and gene therapy. With rare disease, pediatric patients are truly complex and challenging. These trials represent a beacon of hope for children facing rare diseases. https://lnkd.in/gUdfQPXx #RareDiseaseMonth #RareDiseases #ClinicalTrials #ClinicalResearch #ShareYourColors #ShowYourRare

👁️ August #NationalEyeExamMonth in the US, an initiative that reminds us to protect our vision by scheduling routine eye examinations.   ❗Retinitis Pigmentosa (RP) is a highly prevalent group of related eye disorders that impacts an estimated 2 million patients worldwide and is caused by variations in any one of more than 80 genes that affect the retina.   Comprehensive dilated eye exams and genetic testing can be used to identify RP early, allowing for timely intervention.   Our Phase I/II clinical trial, PRODYGY, is currently ongoing in France and the US to assess the safety, tolerability as well as preliminary efficacy and quality-of-life of our lead gene therapy approach for RP, SPVN06.   Learn more about the progress of SPVN06 here: https://lnkd.in/gXHsfYrA   #GenomicMedicines #GeneTherapy #GenomeEditing #Ophthalmology #RetinalDiseases